Ban Woo Ho, Rhee Chin Kook
Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Tuberc Respir Dis (Seoul). 2022 Jul;85(3):221-226. doi: 10.4046/trd.2021.0162. Epub 2022 Mar 8.
Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation due to chronic airway inflammation and destruction of the alveolar structure from persistent exposure to oxidative stress. The body has various antioxidant mechanisms for efficiently coping with such oxidative stress. The nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element (ARE) is a representative system. Dysregulation of the Nrf2-ARE pathway is responsible for the development and promotion of COPD. Furthermore, COPD severity is also closely related to this pathway. There has been a clinical impetus to use Nrf2 for diagnostic and therapeutic purposes. Therefore, in this work, we systematically reviewed the clinical significance of Nrf2 in COPD patients, and discuss the value of Nrf2 as a potential COPD biomarker.
慢性阻塞性肺疾病(COPD)的特征是由于慢性气道炎症和持续暴露于氧化应激导致肺泡结构破坏而引起气流受限。机体具有多种抗氧化机制来有效应对此类氧化应激。核因子红细胞2相关因子2(Nrf2)-抗氧化反应元件(ARE)是一个典型的系统。Nrf2-ARE途径的失调是COPD发生和发展的原因。此外,COPD的严重程度也与该途径密切相关。临床上一直有将Nrf2用于诊断和治疗目的的动力。因此,在本研究中,我们系统地综述了Nrf2在COPD患者中的临床意义,并讨论了Nrf2作为潜在COPD生物标志物的价值。